Clinical Trials Logo

Clinical Trial Summary

Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02655380
Study type Interventional
Source Ajou University School of Medicine
Contact
Status Completed
Phase Phase 4
Start date June 19, 2017
Completion date April 16, 2018

See also
  Status Clinical Trial Phase
Completed NCT01479751 - Comparison of Methods to Facilitate Rapid Sequence Intubation N/A